These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6256403)

  • 1. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH; Gerend PL
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
    Clark OH; Gerend PL
    J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH; Gerend PL; Goretzki P; Nissenson RA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.
    Carayon P; Thomas-Morvan C; Castanas E; Tubiana M
    J Clin Endocrinol Metab; 1980 Oct; 51(4):915-20. PubMed ID: 7419673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH; Gerend PL; Cote TC; Nissenson RA
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
    Field JB; Bloom G; Chou MC; Kerins ME; Larsen PR; Kotani M; Kariya T; Dekker A
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1052-8. PubMed ID: 233688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH; Gerend PL; Nissenson RA
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
    Mandato E; Meldolesi MF; Macchia V
    Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
    Hoermann R; Amir SM; Ingbar SH
    Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive regulation of the guinea pig thyrotropin receptor.
    Davies TF
    Endocrinology; 1985 Jul; 117(1):201-7. PubMed ID: 2988915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
    Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S
    J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
    Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH
    Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
    Siperstein AE; Miller RA; Clark OH
    Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P; Adler G; Roulier R; Lissitzky S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sulfhydryl groups in thyrotropin binding and adenylate cyclase activities of thyroid plasma membranes.
    Ozawa Y; Chopra IJ; Solomon DH; Smith F
    Endocrinology; 1979 Nov; 105(5):1221-5. PubMed ID: 226349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.